BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33395325)

  • 1. Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment.
    Bartziokas K; Papaioannou AI; Haniotou A; Nena E; Kostikas K; Steiropoulos P
    Postgrad Med; 2021 Jun; 133(5):518-524. PubMed ID: 33395325
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia?
    Hira HS; Shukla A; Kaur A; Kapoor S
    Ann Saudi Med; 2012; 32(1):37-42. PubMed ID: 22156638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CPAP treatment on venous lactate and arterial blood gas among obstructive sleep apnea syndrome patients.
    Lin T; Huang JF; Lin QC; Chen GP; Wang BY; Zhao JM; Qi JC
    Sleep Breath; 2017 May; 21(2):303-309. PubMed ID: 27687676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome.
    Steiropoulos P; Kotsianidis I; Nena E; Tsara V; Gounari E; Hatzizisi O; Kyriazis G; Christaki P; Froudarakis M; Bouros D
    Sleep; 2009 Apr; 32(4):537-43. PubMed ID: 19413148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome.
    Czupryniak L; Loba J; Pawlowski M; Nowak D; Bialasiewicz P
    Sleep; 2005 May; 28(5):601-3. PubMed ID: 16171273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome.
    Yosunkaya Ş; Okur HK; Can Ü; Zamani A; Kutlu R
    Metab Syndr Relat Disord; 2015 Aug; 13(6):272-7. PubMed ID: 25867002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome.
    Kallianos A; Panoutsopoulos A; Mermigkis C; Kostopoulos K; Papamichail C; Kokkonouzis I; Kostopoulos C; Nikolopoulos I; Papaiwannou A; Lampaki S; Organtzis J; Pitsiou G; Zarogoulidis P; Trakada G
    Clin Interv Aging; 2015; 10():1361-6. PubMed ID: 26316731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea.
    Uygur F; Tanrıverdi H; Can M; Erboy F; Altınsoy B; Atalay F; Ornek T; Damar M; Kokturk F; Tor M
    Sleep Breath; 2016 Sep; 20(3):939-45. PubMed ID: 26810494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea.
    Can M; Uygur F; Tanrıverdi H; Acıkgoz B; Alper B; Guven B
    Immunol Res; 2016 Dec; 64(5-6):1179-1184. PubMed ID: 27665460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea.
    Wu KM; Lin CC; Chiu CH; Liaw SF
    Chest; 2010 Feb; 137(2):303-9. PubMed ID: 19933373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome.
    Zhang XL; Yin KS; Li C; Jia EZ; Li YQ; Gao ZF
    Chin Med J (Engl); 2007 Sep; 120(17):1477-81. PubMed ID: 17908452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CPAP therapy on insulin-like growth factor and cognitive functions in obstructive sleep apnea patients.
    Kanbay A; Demir NC; Tutar N; Köstek O; Özer Şimşek Z; Buyukoglan H; Demir R; Parrino L
    Clin Respir J; 2017 Jul; 11(4):506-513. PubMed ID: 26260848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP).
    Burioka N; Miyata M; Fukuoka Y; Endo M; Shimizu E
    Chronobiol Int; 2008 Sep; 25(5):827-34. PubMed ID: 18780208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
    Karamanlı H; Özol D; Ugur KS; Yıldırım Z; Armutçu F; Bozkurt B; Yigitoglu R
    Sleep Breath; 2014 May; 18(2):251-6. PubMed ID: 22945540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)].
    Kumor M; Bielicki P; Przybyłowski T; Rubinsztajn R; Zieliński J; Chazan R
    Pneumonol Alergol Pol; 2011; 79(3):173-83. PubMed ID: 21509729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of continuous positive airway pressure treatment of inflammatory factors in patients with overlap syndrome].
    Wang Y; Su M; Zhang X
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):416-9. PubMed ID: 24754983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations.
    Uygur F; Tanriverdi H; Can M; Ornek T; Erboy F; Altinsoy B; Atalay F; Damar M; Kokturk F; Tor M
    Mediators Inflamm; 2016; 2016():8907314. PubMed ID: 26903714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome.
    Hui DS; Ko FW; Fok JP; Chan MC; Li TS; Tomlinson B; Cheng G
    Chest; 2004 May; 125(5):1768-75. PubMed ID: 15136389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary uric acid excretion as an indicator of severe hypoxia and mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
    Ozanturk E; Ucar ZZ; Varol Y; Koca H; Demir AU; Kalenci D; Halilcolar H; Ozacar R
    Rev Port Pneumol (2006); 2016; 22(1):18-26. PubMed ID: 26189914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial.
    Alonso-Fernández A; García-Río F; Arias MA; Hernanz A; de la Peña M; Piérola J; Barceló A; López-Collazo E; Agustí A
    Thorax; 2009 Jul; 64(7):581-6. PubMed ID: 19074930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.